Michael Kuo

Michael Kuo is a visionary leader and the Co-Founder and CEO of Hukui Biotechnology (HKBio), a pioneering company that specializes in Contract Development and Manufacturing Organization (CDMO) services tailored for the Medical Device (MedTech) sector. Under his leadership, HKBio has established itself as a trusted partner for MedTech companies, offering a comprehensive suite of services that spans from prototype design and production planning to regulatory development and clinical trial execution. Michael's expertise in strategic planning and corporate development has been instrumental in guiding HKBio's approach to commercialization strategy, ensuring that clients not only meet regulatory requirements but also achieve market readiness efficiently.

Currently, Michael is spearheading several key projects that focus on enhancing the efficiency and scalability of medical device production. His commitment to quality is evident in HKBio's adherence to stringent GMP and ISO 13485 standards, which are critical for mass production and global market entry. Additionally, Michael's deep understanding of the financial landscape, bolstered by his skills in private equity and financial analysis, allows him to navigate the complexities of funding and investment that are essential for MedTech innovation.

With a strong emphasis on entrepreneurship development, Michael is passionate about fostering growth within the Greater China region, leveraging his extensive network and industry insights to support emerging MedTech companies. His leadership not only drives HKBio’s mission to provide professional solutions for medical device companies but also contributes to the overall advancement of the MedTech industry, making him a key figure in the landscape of biotechnology and medical innovation.